Recreational cannabis use is the driving factor for participation in medical cannabis trials in inflammatory rheumatic diseases
Chatbot use is feasible in phytopharmacological research. Three-quarter of our patients reported some interest in MC CT. Relevant predictors of interest were identified, with a history of cannabis use being the strongest. Understanding and controlling confounders seems crucial for successful planning and conduction of patient-centered future clinical trials in phytomedicine.
Authors
- I Frohne
- J. H. W. Distler
- Gamal Chehab (ORCID: https://orcid.org/0000-0001-7309-2370)
- M Schneider
- Durmuş Sert (ORCID: https://orcid.org/0000-0002-4073-0468)
- Tim Filla (ORCID: https://orcid.org/0000-0001-5628-8398)
- M Aslandag
- Richter Jg
- A Beichert
Institutions
- Düsseldorf University Hospital (DE)
- Heinrich Heine University Düsseldorf (DE)
- Leipzig University (DE)
Publication Details
- Journal
- Phytomedicine
- Published
- 2025-11-22
- DOI
- https://doi.org/10.1016/j.phymed.2025.157599
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00